Vakzine Projekt Management GmbH

General information
Vakzine Projekt Management GmbH
Mellendorfer Str. 9
30625 Hannover, Lower Saxony
Germany

Contact person: Leander Grode, Chief Executive Officer
Company main phone: +49 (511) 1699080
Company main fax:  +49 (511) 16990829
Website:  https://www.vpm-consult.com
Year founded:2002
Source of foundation:Subsidiary
Corporate description / mission:
Vakzine Projekt Management (VPM) is a company that provides consultancy services with a focus on the biopharmaceutical industry. The company specializes in regulatory consultancy, project management, due diligence, quality management, and other areas. The company assists its clients in the development of small molecules, recombinant proteins, gene-modified live vaccines, advanced therapy medicinal products (ATMPs), etc.
State of ownership: Private / independent
Headquarters: No
Remarks on ownership / listings
Serum Institute of India (SIIPL) is majority shareholder of VPM. SIIPL is the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses).
Categorization
Sector:
  • Professional Services and Consulting
Subsector:
  • Due diligence
  • Translation services
Business model:
  • In-licensing
  • R&D
  • Research on contract basis
  • Service company
  • Other
Customer segments:
  • Other
  • Large biotech & big pharma
  • Small biotech
  • Small medtech
Summary Products / Services / Technologies
Description of products:
Services
► Regulatory Consultancy
► Translational Project Management
► Valuation & Due Diligence
► Organizational & Quality Management
► Designated Sponsor
Collaborations & Clients
Partnering strategy / collaborations:
CovidX, priMe, Cruzivax
Serum Institute of India
Client portfolio (as relevant):
small, medium and large biotech companies, big pharmaceutical companies, and academic institutions
© 2023 Biotechgate by Venture Valuation
X